Enimmune Corporation (TPEX:6564)
Taiwan
· Delayed Price · Currency is TWD 18.70
-0.65 (-3.36%)
Apr 29, 2026, 1:24 PM CST
Enimmune Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 202.39 | 484.91 | 359.89 | 394.17 | 118.39 | Upgrade
|
| Short-Term Investments | 23.4 | 4.9 | 4.9 | 92.9 | 231.4 | Upgrade
|
| Cash & Short-Term Investments | 225.79 | 489.81 | 364.79 | 487.07 | 349.79 | Upgrade
|
| Cash Growth | -53.90% | 34.27% | -25.11% | 39.25% | -17.46% | Upgrade
|
| Accounts Receivable | 14.52 | 12.5 | 11.92 | 5.22 | 21.99 | Upgrade
|
| Other Receivables | 31.44 | 29.73 | 28.38 | 28.55 | 25.54 | Upgrade
|
| Receivables | 45.96 | 42.23 | 40.3 | 33.77 | 47.53 | Upgrade
|
| Inventory | 21.23 | 35.64 | 37.64 | 88.12 | 82.82 | Upgrade
|
| Prepaid Expenses | 2.63 | 2.58 | 4.9 | 2.37 | 2.05 | Upgrade
|
| Other Current Assets | 22.57 | 17.79 | 17.59 | 16.54 | 1.37 | Upgrade
|
| Total Current Assets | 318.18 | 588.04 | 465.21 | 627.87 | 483.55 | Upgrade
|
| Property, Plant & Equipment | 14.14 | 3.86 | 5.88 | 8.52 | 5.92 | Upgrade
|
| Other Intangible Assets | 99.08 | 104.17 | 109.27 | 114.38 | 119.48 | Upgrade
|
| Other Long-Term Assets | 24.71 | 27.63 | 24.47 | 24.33 | 1.12 | Upgrade
|
| Total Assets | 456.1 | 723.7 | 604.83 | 775.09 | 610.07 | Upgrade
|
| Accounts Payable | 2.85 | 2.95 | 18.06 | 4 | 10.36 | Upgrade
|
| Accrued Expenses | 29.87 | 19.4 | 32.39 | - | - | Upgrade
|
| Short-Term Debt | 125 | 100 | 40 | 20 | - | Upgrade
|
| Current Portion of Long-Term Debt | 10 | 2.24 | 2.13 | 2.11 | 2.09 | Upgrade
|
| Current Portion of Leases | 3.48 | 0.78 | 1.84 | 1.82 | 0.78 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.72 | Upgrade
|
| Other Current Liabilities | 102.49 | 114.35 | 77.28 | 76.02 | 19.88 | Upgrade
|
| Total Current Liabilities | 273.7 | 239.71 | 171.7 | 103.95 | 34.82 | Upgrade
|
| Long-Term Debt | 28.22 | 4.78 | 0.98 | 3.11 | 5.22 | Upgrade
|
| Long-Term Leases | 4.49 | - | 0.78 | 2.62 | - | Upgrade
|
| Total Liabilities | 306.41 | 244.49 | 173.46 | 109.68 | 40.04 | Upgrade
|
| Common Stock | 721.34 | 721.34 | 658 | 658 | 600 | Upgrade
|
| Additional Paid-In Capital | 25.67 | 160.64 | 11.56 | 168.02 | 17.27 | Upgrade
|
| Retained Earnings | -588.81 | -509.82 | -344.93 | -281.33 | -47.25 | Upgrade
|
| Comprehensive Income & Other | -8.51 | 1.91 | -2.68 | -0.15 | - | Upgrade
|
| Total Common Equity | 149.69 | 374.06 | 321.95 | 544.54 | 570.03 | Upgrade
|
| Minority Interest | - | 105.14 | 109.41 | 120.87 | - | Upgrade
|
| Shareholders' Equity | 149.69 | 479.2 | 431.36 | 665.41 | 570.03 | Upgrade
|
| Total Liabilities & Equity | 456.1 | 723.7 | 604.83 | 775.09 | 610.07 | Upgrade
|
| Total Debt | 171.19 | 107.8 | 45.73 | 29.66 | 8.08 | Upgrade
|
| Net Cash (Debt) | 54.59 | 382 | 319.06 | 457.41 | 341.7 | Upgrade
|
| Net Cash Growth | -85.71% | 19.73% | -30.25% | 33.86% | -17.02% | Upgrade
|
| Net Cash Per Share | 0.76 | 5.34 | 4.85 | 7.16 | 5.70 | Upgrade
|
| Filing Date Shares Outstanding | 72.13 | 72.13 | 65.8 | 65.8 | 60 | Upgrade
|
| Total Common Shares Outstanding | 72.13 | 72.13 | 65.8 | 65.8 | 60 | Upgrade
|
| Working Capital | 44.47 | 348.33 | 293.51 | 523.92 | 448.73 | Upgrade
|
| Book Value Per Share | 2.08 | 5.19 | 4.89 | 8.28 | 9.50 | Upgrade
|
| Tangible Book Value | 50.61 | 269.9 | 212.68 | 430.16 | 450.55 | Upgrade
|
| Tangible Book Value Per Share | 0.70 | 3.74 | 3.23 | 6.54 | 7.51 | Upgrade
|
| Machinery | 6.5 | 5.39 | 4.92 | 4.92 | 4.65 | Upgrade
|
| Leasehold Improvements | 5.67 | 2.6 | 2.6 | 2.6 | 2.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.